Market Tracker

04/23 6:05pm ET

Progenics Pharmaceuticals Inc (NASDAQ:PGNX)

During the Trading Day
3.72 -0.17 / -4.37%
Data as of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
3.72 -0.0004 / -0.01%
 
Volume: 10.8K

Today’s Trading

Previous close3.89
Today’s open3.90
Day’s range3.70 - 3.92
Volume602,632
Average volume (3 months)1,422,427
Market cap$243.5M
Dividend yield--
Data as of 3:59pm ET, 04/23/2014

Growth & Valuation

Earnings growth (last year)+25.49%
Earnings growth (this year)+22.37%
Earnings growth (next 5 years)+7.00%
Revenue growth (last year)-44.03%
P/E ratioNM
Price/Sales37.83
Price/Book2.70

Competitors

 Today’s
change
Today’s
% change
SRNESorrento Therapeutic...0.000.00%
AKAOAchaogen Inc-0.68-4.88%
NAVBNavidea Biopharmaceu...-0.02-1.14%
SCLNSciClone Pharmaceuti...-0.04-0.85%
Data as of 4:05pm ET, 04/23/2014

Financials

Next reporting dateMay 12, 2014
EPS forecast (this quarter)-$0.15
Annual revenue (last year)$7.9M
Annual profit (last year)-$42.6M
Net profit margin-541.49%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mark Robert Baker
Chief Financial Officer, Treasurer, CAO &
VP
Angelo William Lovallo
Corporate headquarters
Tarrytown, New York

Forecasts